Evidence map›Paper›PMID 35664958›Full record

Trial reportWorld journal of gastroenterology2022

Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia.

Simone Baldi, Giuditta Pagliai, Monica Dinu, Leandro Di Gloria, Giulia Nannini, Lavinia Curini, Marco Pallecchi, Edda Russo, Elena Niccolai, Giovanna Danza and 7 more

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in World journal of gastroenterology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07403929 (Determination of the Effect of Fermented Grape Juice Consumption on Oxidative Stress and Inflammation Biomarkers and SIRT-1 Levels in Fibromyalgia Patients), which is not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07403929 narecruitingnot on this mapstarted 2026, after this paper: background citation

Determination of the Effect of Fermented Grape Juice Consumption on Oxidative Stress and Inflammation Biomarkers and SIRT-1 Levels in Fibromyalgia Patients

TypeinterventionalSponsorHacettepe UniversityRan2026 to 2027Enrolled45ConditionsFibromyalgia, Fibromyalgia (FM), Fibromyalgia Syndrome, PrimaryArmsMedical Nutrition Therapy (MNT), Hardaliye (200 mL/day)
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Microbiome: A Key Regulator of Body-Brain Interactions.Advances in experimental medicine and biology · 2025
    Review
  10. Review
  11. Observational
  12. Biology of Anemia: A Public Health Perspective.The Journal of nutrition · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Simone BaldiDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Giuditta PagliaiDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Monica DinuDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Leandro Di GloriaDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Giulia NanniniDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Lavinia CuriniDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Marco PallecchiDepartment of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Sesto Fiorentino 50019, Italy.
Edda RussoDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Elena NiccolaiDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Giovanna DanzaDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence 50134, Italy.
Stefano BenedettelliDepartment of Agriculture, Food, Environment and Forestry, University of Florence, Florence 50144, Italy.
Giovanna BalleriniMultidisciplinary Center for Pain Therapy, Reference Center for Fibromyalgia, Piero Palagi Hospital, USL Toscana Centro, Florence 50122, Italy.
Barbara ColombiniDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Gianluca BartolucciDepartment of Neurosciences, Psychology, Drug Research and Child Health, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Sesto Fiorentino 50019, Italy.
Matteo RamazzottiDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence 50134, Italy.
Francesco SofiDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
Amedeo AmedeiDepartment of Experimental and Clinical Medicine, University of Florence, Florence 50134, Italy.
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFibromyalgia (FM) syndrome is mainly characterized by widespread pain, sleeping disorders, fatigue, and cognitive dysfunction. In many cases, gastrointestinal distress is also reported, suggesting the potential pathogenic role of the gut microbiota (GM). The GM is deeply influenced by several environmental factors, especially the diet, and recent findings highlighted significant symptom improvement in FM patients following various nutritional interventions such as vegetarian diet, low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols based diets, gluten-free diet, and especially an ancient grain supplementation. In particular, a recent study reported that a replacement diet with ancient Khorasan wheat led to an overall improvement in symptom severity of FM patients.

aimTo examine the effects of ancient Khorasan wheat on the GM, inflammation, and short-chain fatty acid production in FM patients.

methodsAfter a 2-wk run-in period, 20 FM patients were enrolled in this randomized, double-blind crossover trial. In detail, they were assigned to consume either Khorasan or control wheat products for 8 wk and then, following an 8-wk washout period, crossed. Before and after treatments, GM characterization was performed by 16S rRNA sequencing while the fecal molecular inflammatory response and the short-chain fatty acids (SCFAs) were respectively determined with the Luminex MAGPIX detection system and a mass chromatography-mass spectrometry method.

resultsThe Khorasan wheat replacement diet, in comparison with the control wheat diet, had more positive effects on intestinal microbiota composition and on both the fecal immune and SCFAs profiles such as the significant increase of butyric acid levels (

conclusionThe replacement diet based on ancient Khorasan wheat results in beneficial GM compositional and functional modifications that positively correlate with an improvement of FM symptomatology.

Indexed as

FibromyalgiaGastrointestinal MicrobiomeDiet, Gluten-FreeFatty Acids, VolatileHumansInflammationPainRNA, Ribosomal, 16STriticumFatty Acids, VolatileRNA, Ribosomal, 16SAncient wheatFibromialgyaFibromialgya symptomsGut microbiotaKhorasan wheat

Identifiers

PMID35664958
PMCPMC9150053
OpenAlexW4229028884

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.